Related Experiment Video
Updated: May 29, 2026
04:24
A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
Published on: April 19, 2019
Pilates in heart failure patients: a randomized controlled pilot trial.
Guilherme Veiga Guimarães1, Vitor Oliveira Carvalho, Edimar Alcides Bocchi
1Heart Institute do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, (InCor-HCFMUSP). gvguima@usp.br
Cardiovascular Therapeutics
|September 3, 2011
Summary
Pilates training significantly improved exercise capacity in heart failure (HF) patients, enhancing ventilation and oxygen uptake compared to conventional cardiac rehabilitation. This suggests Pilates is a beneficial adjunctive therapy for improving functional capacity in HF.
Area of Science:
- Cardiology
- Exercise Physiology
- Rehabilitation Medicine
Background:
- Conventional cardiac rehabilitation involves aerobic and calisthenics exercise.
- The therapeutic benefits of the Pilates method are recognized, but evidence for its use in heart failure (HF) patients is limited.
Purpose of the Study:
- To investigate the effects of Pilates on exercise capacity in patients with heart failure (HF).
Main Methods:
- Sixteen HF patients (NYHA class I-II) were randomized into conventional cardiac rehabilitation (n=8) or mat Pilates (n=8) groups.
- Both groups underwent 16 weeks of training, including 30 minutes of aerobic exercise, followed by 20 minutes of their specific program.
Main Results:
- The Pilates group showed significant increases in exercise time, ventilation, peak VO2, and O2 pulse.
- Pilates group demonstrated a significantly greater increase in peak VO2 compared to the conventional group.
Conclusions:
- The Pilates method may serve as a beneficial adjunctive treatment for enhancing functional capacity in heart failure patients.
- Pilates improves key exercise capacity variables in HF patients beyond standard cardiac rehabilitation.
More Related Videos
Related Concept Videos
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:30Heart Failure VII: Nursing Interventions
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
01:27Heart Failure I: Introduction
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
01:26Heart Failure Drugs: Inotropic Agents
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
01:26Heart Failure III: Clinical Manifestations
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...